Stay updated on Ipilimumab Nivolumab Combo in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab Nivolumab Combo in Melanoma Clinical Trial page.

Latest updates to the Ipilimumab Nivolumab Combo in Melanoma Clinical Trial page
- Check7 days agoChange DetectedThe page’s footer revision number was updated from v3.5.2 to v3.5.3, indicating a maintenance/version update rather than a change to the study information.SummaryDifference0.1%

- Check14 days agoChange DetectedA new Revision: v3.5.2 was added and the previous Revision: v3.5.0 was removed from the page's revision history.SummaryDifference0.1%

- Check21 days agoChange DetectedThe page now includes Melanoma and related topics, such as MedlinePlus Genetics.SummaryDifference0.2%

- Check29 days agoChange DetectedMelanoma and the related topic MedlinePlus Genetics were removed from the page.SummaryDifference0.2%

- Check43 days agoChange DetectedAdded Melanoma label and related topics (MedlinePlus Genetics). Site revision updated to v3.5.0, replacing v3.4.3.SummaryDifference0.2%

- Check50 days agoChange DetectedRevision: v3.4.3 added and v3.4.2 removed.SummaryDifference0.1%

Stay in the know with updates to Ipilimumab Nivolumab Combo in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab Combo in Melanoma Clinical Trial page.